Sabra Health Care REIT, Inc.·4

Jun 18, 6:33 PM ET

Cusack Catherine 4

Research Summary

AI-generated summary

Updated

Sabra Health Care (SBRA) Director Catherine Cusack Receives Award

What Happened Catherine Cusack, a director of Sabra Health Care REIT (SBRA), was granted 8,310 restricted stock units (transaction code A) on 2026-06-17. The reported acquisition price is $0.00 (award/compensation), so no cash was paid. The filing indicates she holds a total of 63,326 stock units after the grant (8,310 unvested units from this award plus 55,016 vested units for which payment has been deferred). Each stock unit represents the right to one share of common stock.

Key Details

  • Transaction date: 2026-06-17; Form 4 filed 2026-06-18 (timely).
  • Transaction type/code: Award/Grant (A) — restricted stock units (RSUs).
  • Quantity granted: 8,310 RSUs; reported price: $0.00; total reported additional cash value: $0.
  • Shares/units owned after transaction: 63,326 stock units (8,310 unvested + 55,016 vested but payment deferred).
  • Vesting (Footnote F1): RSUs vest in equal monthly installments starting July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.
  • Footnote F2 clarifies each stock unit equals one share and separates unvested units from vested units with deferred payment.
  • Exhibit: Power of Attorney included.

Context This was a compensation award (RSUs), not an open-market purchase or sale. RSU grants are common for directors and reflect compensation rather than a direct market bet; vesting schedule determines when units convert to shares. Vested-but-deferred units indicate she has earned those units but has elected (or is required) to defer receipt of the shares or cash.